Accelerator Corporation, a Seattle-based biotechnology investment company, has launched XORI Corporation, an antibody discovery and development platform. XORI received a Series A investment from Alexandria Real Estate Equities; Amgen Ventures; ARCH Venture Partners, Inc.; OVP Venture Partners; PPD, Inc.; and WRF Capital.
